The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Pete Stavropoulos; Analyst; Cantor Fitzgerald & Co. Good afternoon and welcome to Voyager Therapeutics fourth-quarter and year-end 2024 financial results conference call. (Operator Instructions) ...

UCB understands that business is personal—and so is their approach. Whether a business is just starting or ready to expand, ...

Multiple Sclerosis Therapeutics Size Multiple Sclerosis Therapeutics Market is estimated to be valued at USD 31.39 Bn in 2025 and is expect ...

Learn more about whether Inter & Co, Inc. or United Community Banks, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.